TATJANA ACKER: Open Payments
NPI 1821161696 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,285 in 84 payments from 17 companies in 2025. Trend: 2023 $1,510 · 2024 $1,273 · 2025 $1,285
Food & beverage: $1,285
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 22 | $247 |
| Lilly USA, LLC | 15 | $194 |
| ABBVIE INC. | 10 | $185 |
| PFIZER INC. | 4 | $86 |
| Phathom Pharmaceuticals, Inc. | 8 | $72 |
| Amgen Inc. | 4 | $59 |
| Abbott Laboratories | 2 | $56 |
| Inspire Medical Systems, Inc. | 2 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $51 |
Products named: VRAYLAR, MOUNJARO, Ozempic, VOQUEZNA, Rybelsus, PREVNAR 20, JARDIANCE, INSPIRE.
Industry payments across AL — which companies pay providers there.
